These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [How beautiful is prevention that still eludes...]. Bobbio M Epidemiol Prev; 1991 Jun; 13(47):6-12. PubMed ID: 1838508 [No Abstract] [Full Text] [Related]
25. [Primary and secondary prevention of coronary disease by statins]. Ferrières J Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337 [TBL] [Abstract][Full Text] [Related]
26. [Primary and secondary prevention of arteriosclerosis. Risk stratification of hypertension]. Gysan DB Z Kardiol; 2002 Oct; 91(10):777-85. PubMed ID: 12395218 [TBL] [Abstract][Full Text] [Related]
27. Hormones, menopause, and heart disease: making sense of the Women's Health Initiative. Derry PS Womens Health Issues; 2004; 14(6):212-9. PubMed ID: 15589771 [TBL] [Abstract][Full Text] [Related]
28. Plant stanol esters are potentially cost-effective in the prevention of coronary heart disease in men: Bayesian modelling approach. Martikainen JA; Ottelin AM; Kiviniemi V; Gylling H Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):265-72. PubMed ID: 17446806 [TBL] [Abstract][Full Text] [Related]
29. The vitamin E saga: lessons in patient-oriented evidence. Ebell MH Am Fam Physician; 2005 Jun; 71(11):2052, 2054. PubMed ID: 15952434 [No Abstract] [Full Text] [Related]
30. Clinical trials of uric acid lowering for coronary heart disease risk reduction. Simon JA Am J Med; 2006 Apr; 119(4):e5; author reply e7. PubMed ID: 16564763 [No Abstract] [Full Text] [Related]
31. Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones. Rossouw JE Maturitas; 2005 May; 51(1):51-63. PubMed ID: 15883110 [TBL] [Abstract][Full Text] [Related]
32. Commentary: the hormone replacement-coronary heart disease conundrum: is this the death of observational epidemiology? Lawlor DA; Davey Smith G; Ebrahim S Int J Epidemiol; 2004 Jun; 33(3):464-7. PubMed ID: 15166201 [No Abstract] [Full Text] [Related]
33. Trends in diet quality for coronary heart disease prevention between 1980-1982 and 2000-2002: The Minnesota Heart Survey. Lee S; Harnack L; Jacobs DR; Steffen LM; Luepker RV; Arnett DK J Am Diet Assoc; 2007 Feb; 107(2):213-22. PubMed ID: 17258957 [TBL] [Abstract][Full Text] [Related]
37. [The CARDS Study: cardiovascular primary prevention in diabetes patients using Atorvastin]. Griebenow R Internist (Berl); 2005 Mar; 46(3):350-2. PubMed ID: 15696286 [No Abstract] [Full Text] [Related]
38. [Acute coronary syndromes without ST-segment elevation. From randomized clinical trials, to consensus guidelines, to clinical practice in Italy: need to close the circle]. Savonitto S; Klugmann S Ital Heart J Suppl; 2004 Mar; 5(3):167-76. PubMed ID: 15116860 [TBL] [Abstract][Full Text] [Related]
39. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease. Mohandas B; Mehta JL Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545 [TBL] [Abstract][Full Text] [Related]
40. N-3 fatty acids and the primary prevention of coronary artery disease. Dubnov G; Berry EM Isr Med Assoc J; 2004 Aug; 6(8):507-8; author reply 508. PubMed ID: 15326841 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]